TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Human Papillomavirus (HPV) Vaccines Market – By Type
1.3.2 APAC Human Papillomavirus (HPV) Vaccines Market – By Dosage
1.3.3 APAC Human Papillomavirus (HPV) Vaccines Market – By Age
1.3.4 APAC Human Papillomavirus (HPV) Vaccines Market – By Application
1.3.5 APAC Human Papillomavirus (HPV) Vaccines Market – By Distribution Channel
1.3.6 APAC Human Papillomavirus (HPV) Vaccines Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Human Papillomavirus (HPV) Vaccine Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Human Papillomavirus (HPV) Vaccine Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of HPV Associated Diseases
5.1.2 Initiatives Taken by Health Organizations
5.2 Market Restraints
5.2.1 High Cost of HPV Vaccines
5.3 Market Opportunities
5.3.1 Growing Number of HPV Awareness Programs
5.4 Future Trends
5.4.1 Advancements in HPV Diagnostics Tests
5.5 Impact Analysis
6. Human Papillomavirus (HPV) Vaccine Market– APAC Analysis
6.1 APAC Human Papillomavirus (HPV) Vaccine Market Revenue Forecast and Analysis
7. APAC Human Papillomavirus (HPV) Vaccine Market Analysis – By Type
7.1 Overview
7.2 By Type: Market Revenue and Forecast Analysis (US$ Million)
7.3 9-valent HPV vaccine
7.3.1 Overview
7.3.2 9-valent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
7.4 Quadrivalent HPV vaccine
7.4.1 Overview
7.4.2 Quadrivalent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
7.5 Bivalent HPV Vaccine
7.5.1 Overview
7.5.2 Bivalent HPV Vaccine Market Revenue and Forecast to 2028 (US$ Million)
8. APAC Human Papillomavirus (HPV) Vaccine Market Analysis - By Dosage
8.1 APAC Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Dosage (2022 and 2028)
8.2 2 Dose
8.2.1 Overview
8.2.2 2 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
8.3 3 Dose
8.3.1 Overview
8.3.2 3 Dose: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
9. APAC Human Papillomavirus (HPV) Vaccine Market Analysis - By Age
9.1 APAC Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Age (2022 and 2028)
9.2 9 to 14 Years
9.2.1 Overview
9.2.2 9 to 14 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
9.3 to 45 Years
9.3.1 Overview
9.3.2 to 45 Years: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
10. APAC Human Papillomavirus (HPV) Vaccine Market Analysis - By Application
10.1 APAC Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Application (2022 and 2028)
10.2 HPV-attributable Cancer
10.2.1 Overview
10.2.2 HPV-attributable Cancer: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
10.3 Genital Warts
10.3.1 Overview
10.3.2 Genital Warts: Human Papillomavirus (HPV) Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
11. APAC Human Papillomavirus (HPV) Vaccine Market Analysis – By End User
11.1 Overview
11.2 APAC Human Papillomavirus (HPV) Vaccine Market Revenue Share, by End User (2022 and 2028)
11.3 Doctor Office
11.3.1 Overview
11.3.2 Doctor Office Market Revenue and Forecast to 2028 (US$ Million)
11.4 Community Health Clinics
11.4.1 Overview
11.4.2 Community Health Clinics Market Revenue and Forecast to 2028 (US$ Million)
11.5 School-based Health Centers
11.5.1 Overview
11.5.2 School-based Health Centers Market Revenue and Forecast to 2028 (US$ Million)
11.6 Health Departments
11.6.1 Overview
11.6.2 Health Departments Market Revenue and Forecast to 2028 (US$ Million)
11.7 Hospitals
11.7.1 Overview
11.7.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million)
11.8 Others
11.8.1 Overview
11.8.2 Others Market Revenue and Forecast to 2028 (US$ Million)
12. APAC Human Papillomavirus (HPV) Vaccine Market - Country Analysis
12.1 Overview
12.1.1 APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Country (2022 & 2028)
12.1.1.1 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.1 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.2 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.1.1.1.3 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.1.1.1.4 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.1.1.1.5 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.1.1.1.6 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.1.1.2 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.1 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.2 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.1.1.2.3 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.1.1.2.4 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.1.1.2.5 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.1.1.2.6 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.1.1.3 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.1 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.2 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.1.1.3.3 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.1.1.3.4 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.1.1.3.5 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.1.1.3.6 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.1.1.4 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.4.1 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.4.2 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.1.1.4.3 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.1.1.4.4 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.1.1.4.5 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.1.1.4.6 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.1.1.5 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.5.1 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.5.2 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.1.1.5.3 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.1.1.5.4 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.1.1.5.5 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.1.1.5.6 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.1.1.6 New Zealand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.6.1 New Zealand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.6.2 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.1.1.6.3 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.1.1.6.4 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.1.1.6.5 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.1.1.6.6 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.1.1.7 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.7.1 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.7.2 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.1.1.7.3 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.1.1.7.4 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.1.1.7.5 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.1.1.7.6 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.1.1.8 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.8.1 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.8.2 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.1.1.8.3 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.1.1.8.4 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.1.1.8.5 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.1.1.8.6 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.1.1.9 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.9.1 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.9.2 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.1.1.9.3 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.1.1.9.4 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.1.1.9.5 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.1.1.9.6 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.1.1.10 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.10.1 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.10.2 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.1.1.10.3 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.1.1.10.4 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.1.1.10.5 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.1.1.10.6 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.1.1.11 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.11.1 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.11.2 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.1.1.11.3 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.1.1.11.4 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.1.1.11.5 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.1.1.11.6 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.1.1.12 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.1.1.12.1 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
12.1.1.12.2 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.1.1.12.3 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.1.1.12.4 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.1.1.12.5 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.1.1.12.6 Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
13. Industry Landscape
13.1 Overview
13.2 Inorganic Growth Strategies
13.2.1 Overview
13.3 Organic Growth Strategies
13.3.1 Overview
14. Company Profiles
14.1 Merck & Co., Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 GlaxoSmithKline plc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 INNOVAX Xiamen Innovax Biotech CO., LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Serum Institute of India Pvt. Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Walvax Biotechnology Co., Ltd.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Inovio Pharmaceuticals
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Vaccitech
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 ChengDu Institute of Biological Products Co., Ltd.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sanofi
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 R-Pharm
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES.
Table 1. APAC Human Papillomavirus (HPV) Vaccine Market, Revenue and Forecast, 2019–2028 (US$ Mn)
Table 2. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 3. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 4. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 5. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 6. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 7. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 8. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 9. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 10. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 11. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 12. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 13. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 14. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 15. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 16. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 17. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 18. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 19. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 20. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 21. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 22. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 23. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 24. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 25. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 26. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 27. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 28. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 29. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 30. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 31. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 32. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 33. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 34. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 35. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 36. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 37. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 38. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 39. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 40. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 41. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 42. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 43. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 44. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 45. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 46. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 47. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 48. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 49. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 50. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 51. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 52. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 53. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 54. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 55. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 56. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 57. Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 58. Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 59. Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 60. Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 61. Rest of APAC: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 62. Recent Inorganic Growth Strategies
Table 63. Recent Organic Growth Strategies
Table 64. Glossary of Terms